Pfenex Inc (PFNX) Stock Overview
USA - NYSEARCA:PFNX -
PFNX Key Statistics, Chart & Performance
The current stock price of PFNX is 12.75 null. In the past month the price increased by 1.03%. In the past year, price increased by 70.91%.
PFNX Latest News, Press Relases and Analysis
About PFNX
Company Profile
Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California.
Company Info
Pfenex Inc
10790 ROSELLE STREET
SAN DIEGO CA 92121
CEO: Evert B. Schimmelpennink
Phone: 858-352-4400
Pfenex Inc / PFNX FAQ
Can you describe the business of Pfenex Inc?
Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform to build a pipeline of product candidates and preclinical products under development including other biosimilars, as well as vaccines, generics and next generation biologics. Pfenex Inc. is headquartered in San Diego, California.
Can you provide the latest stock price for Pfenex Inc?
The current stock price of PFNX is 12.75 null. The price decreased by -0.08% in the last trading session.
What is the dividend status of Pfenex Inc?
PFNX does not pay a dividend.
What is the ChartMill rating of Pfenex Inc stock?
PFNX has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of Pfenex Inc (PFNX)?
Pfenex Inc (PFNX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).
Can you provide the ownership details for PFNX stock?
You can find the ownership structure of Pfenex Inc (PFNX) on the Ownership tab.
PFNX Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to PFNX. When comparing the yearly performance of all stocks, PFNX is one of the better performing stocks in the market, outperforming 93.5% of all stocks.
PFNX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PFNX. PFNX has an excellent financial health rating, but there are some minor concerns on its profitability.
PFNX Financial Highlights
Over the last trailing twelve months PFNX reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by 75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -14.1% | ||
| ROA | -6.76% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |